[Dilip Davda] While diagnostic / healthcare service sector is flourishing and many new entrants are emerging, it is becoming a highly competitive segment. However, established big players may hold the key to the success of small ventures. Although based on super earnings of FY20 Q1, the issue appears attractively priced, but the sustainability of such performance going forward is a major concern. Considering all these, cash surplus - risk savvy investors may consider investment at their own risk. Read detail review...

Gian Life Care IPO Review by Members

Gian Life Care IPO Reviews, analysis and views by popular members. Read Gian Life Care Ltd. IPO reviews by retail investors to find recommended ipo to buy.

Gian Life Care IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%	0.00	0.00	0.00	0.00

Member	Review
No recommendation found. Be the first to post the recommendation.

Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

Gian Life Care IPO Review & Recommendations

Gian Life Care IPO Review Summary from brokers and analysts

Gian Life Care IPO Review by Dilip Davda May apply

Gian Life Care IPO Review by Members

Gian Life Care IPO Review Summary by Members

Read more about Gian Life Care IPO